RGC (Regencell Bioscience) Earnings per share growth rate in current year
Regencell Bioscience (RGC) generates revenue by implementing natural treatments for autism and ADHD, yet faces intense pressure from traditional neurology. The year-over-year shift in earnings per share on GURU.Markets illustrates the outcome of this struggle, where the 0.00 metric reflects current dynamics. Strategically, Regencell Bioscience relies on outsourcing clinical trials through contract laboratories.
Financial and market metric breakdowns for Regencell Bioscience (RGC)
- price and consensus price forecast:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
All Debt to Shareholders' Equity Ratio Regencell Bioscience|RGC - Long-Term Debt to Capital|Short-Term Debt to Equity regencellbioscience.com|RGC - Company Aggregate Debts|Debts to Net Assets Regencell Corp|RGC - Company Long-Term Debt|Short-Term Debt Regencell Bioscience|Interim Coverage Ratio regencellbioscience.com
- earnings and valuation multiples information:
RGC - Net Profit|Future Profit Regencell Bioscience|RGC - P/E Multiple|Market Cap to Projected Earnings Regencell Corp|RGC - PEG Multiple|Company Value to EBITDA Regencell Corp|RGC - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Regencell Bioscience|RGC - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months regencellbioscience.com|RGC - Earnings growth in current year|Expected net earnings per share growth next year Regencell Bioscience
Fundamental valuation:RGC - Regencell Bioscience Ltd
For Regencell Bioscience (RGC), which relies on a lean staff of neurobiologists and targeted grants, net earnings per share dynamics serve as an indicator of how effectively the company capitalizes on its scientific achievements. Analyzing the change in EPS compared to the previous year allows for an assessment of profit growth rates relative to the preceding period, helping investors determine the business development phase and avoid overpaying for the asset.
Main competitors
Net earnings per share growth this year Biogen Inc|NBIX (Neurocrine Biosciences Inc) - Earnings growth in current year|Earnings per share growth rate in current year Axsome Corp AXSM|Earnings per share growth in current year ACADIA Pharmaceuticals (ACAD)|Earnings per share growth in current year XENE (xenon-pharma.com)|Earnings per share growth in current year Viking Therapeutics, Inc. VKTX|Supernus Pharmaceuticals, Inc. - Earnings per share growth in current year|CPRX: Net earnings per share growth this year|Earnings per share increase in current year DNLI (Denali Corp)|HRMY: Earnings growth in current year|BHVN (biohavenpharma.com) - Earnings per share growth in current year|AMLX (Amylyx Pharmaceuticals, Inc.) - Earnings growth in current year|Trevi Therapeutics Inc (TRVI) - Expected net earnings per share growth this year|Earnings per share growth in current year Praxis Medicines (PRAX)|AVXL - Earnings per share growth rate in current year|Earnings per share growth in current year CeriBell, Inc. CBLL|Expected net earnings per share growth this year prothena.com (PRTA)|Alector Therapeutics - Earnings growth in current year|Annexon Biosciences (ANNX) - Net earnings per share growth this year|OMER: Earnings growth in current year|NGNE - Expected net earnings per share growth this year|ACIU (AC Immune) - Earnings growth in current year|Earnings per share growth rate in current year voyagertherapeutics.com VYGR|Earnings per share growth in current year Neumora Therapeutics, Inc. (NMRA)|Scilex Holding - Earnings per share growth this year|Earnings growth in current year TVGN (Tevogen Bio Holdings, Inc.)|ACOG - Net earnings per share growth this year|Cognition Therapeutics, Inc. - Earnings growth in current year|Earnings per share growth rate in current year inhibikase.com|Cassava Sciences (SAVA) - Earnings per share growth in current year|Assertio - Earnings per share increase in current year|COYA (Coya Therapeutics Inc) - Earnings growth in current year|VTGN - Net earnings per share change in current year|Earnings growth in current year OVID|Net earnings per share growth this year acumenpharm.com ABOS|Earnings per share growth in current year CervoMed CRVO|ATHE: Earnings per share growth this year|Clene Nanomedicine - Earnings growth in current year|Earnings per share growth rate in current year PepGen Inc.|JUNS (Jupiter Neurosciences) - Net earnings per share growth this year|relmada.com (RLMD) - Earnings growth in current year|Earnings per share growth in current year Annovis Bio|GRCE: Earnings per share increase in current year|Earnings per share growth in current year Firefly Neuroscience Inc (AIFF)|KLTO - Earnings per share growth rate in current year|Earnings per share growth in current year NeuroSense Therapeutics Ltd. NRSN|Earnings per share increase in current year RVPH|MetaVia, Inc. - Earnings growth in current year|Earnings per share growth rate in current year NeurAxis Inc.|HSDT: Earnings growth in current year|Net earnings per share change in current year Passage Bio PASG|NEUP (Neuphoria Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year minervaneurosciences.com NERV|Earnings per share growth in current year Athira Pharma (ATHA)|Addex Therapeutics Ltd. - Earnings per share growth this year|Earnings growth in current year ALZN (Alzamend Neuro)|CYCN - Net earnings per share growth this year|Protagenic - Earnings growth in current year|Earnings per share growth rate in current year Pasithea Therapeutics|cortigent.com (CRGT) - Earnings per share growth in current year|ATXI (Avenue Therapeutics Inc.) - Earnings per share growth in current year|Earnings per share growth in current year Brainstorm Cell Therapeutics, Inc.|Earnings per share growth in current year CARA|Net earnings per share growth this year CHRO (Chromocell Therapeutics)|ELYM (eliemtx.com) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies, Inc.)|Longboard Pharmaceuticals Inc - Earnings per share growth in current year|Marinus - Earnings growth in current year|Expected net earnings per share growth this year NKGen Biotech Corp NKGN|NeuroBo Pharmaceuticals (NRBO) - Earnings per share growth in current year|Earnings per share growth rate in current year sagerx.com (SAGE)|Earnings per share growth in current year Synaptogenix|Trevena Inc. (TRVN) - Expected net earnings per share growth this year|Earnings growth in current year VIGL|Net earnings per share growth this year anewmeds.com WENA|Earnings growth in current year CERE (Cerevel Therapeutics)
